EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A self-complementary recombinant adeno-associated virus vector coding for an anchorless prion protein carrying the G127V mutation extends survival in a rodent prion disease model

Thomas Zerbes, Claire Verkuyl, Cunjie Zhang, Sophie Grunnesjoe, Shehab Eid, Hamza Arshad, Wenda Zhao, Zahra Nasser, Teaghan O'Shea, Ari Bel, Lise Lamoureux, Kathy L Frost und 7 weitere

PLOS Pathogens · 2026

DOI: 10.1371/journal.ppat.1014124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2026. Verfasst von Thomas Zerbes und 18 weiteren Autor:innen. Beteiligte Einrichtung: Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Dependovirus, Genetic Vectors, Prion Diseases, Prions. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Canadian Institutes of Health Research, CFI/ORF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The replacement of a single codon in the human prion gene, causing the substitution of glycine with valine at position 127 (G127V) of the prion protein (PrP), prevents development of prion disease. We set out to explore if prion disease survival extension manifests in mice if the V127 mutant is delivered through a recombinant adeno-associated virus (rAAV) packaged as a self-complementary DNA. The notorious delivery limitations of rAAV vectors were designed to be overcome using a cross-correction approach that relied on the expression of the mutation in the context of glycosylphosphatidylinositoI-anchorless (ΔGPI) PrP. In this proof-of-concept study, we inoculated Rocky Mountain Laboratory (RML) prions into knock-in mice, in which the endogenous murine prion protein gene ( Prnp ) was replaced with the bank vole prion protein gene (Bv Prnp ). Prion-inoculated mice that were retro-orbitally transduced with a protective rAAV vector encoding Bv Prnp V127 ΔGPI survived ~50 days longer than control mice that were unprotected. A deep proteomic analysis revealed that Bv Prnp V127 ΔGPI was protective by slowing perturbations to the proteome observed in late-stage RML prion disease. In addition to capturing details of synaptic decay and depletion of proteins in proximity to PrP, the proteomic dataset revealed the identity of proteins of potential diagnostic value that may be central to the brain’s attempt to fight prion disease by contributing to astrocytosis or microgliosis, by coping with calcium influx, or by enhancing the endoplasmic reticulum processing of essential proteins. Taken together, our results demonstrate that a gene therapy based on a GPI-anchorless PrP containing the G127V mutation can delay the onset of prion disease in mice, providing a framework for development of a corresponding therapy in humans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DependovirusGenetic VectorsPrion DiseasesPrionsPrion ProteinsAnimalsMiceDisease Models, AnimalMutationHumans

Substanzen

PrionsPrion Proteins

Autor:innen und Institutionen

  • Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada.
  • Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, Ontario, Canada.
  • Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.
  • Department of Biochemistry & Centre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, Alberta, Canada.

ORCID-Profile: Gerold Schmitt-Ulms

Förderung

  • NIAID NIH HHS
  • Canadian Institutes of Health Research
  • CFI/ORF
  • Krembil Foundation
  • Krembil Brain Institute
  • National Institutes of Health
  • Canadian Graduate Scholarship

Zitieren

APA

Zerbes, T., Verkuyl, C., Zhang, C., Grunnesjoe, S., Eid, S., Arshad, H., Zhao, W., Nasser, Z., O'Shea, T., Bel, A., Lamoureux, L., Frost, K. L., Myskiw, J., Li, L. Y., Stuart, E., Wille, H., Booth, S., Watts, J. C., & Schmitt-Ulms, G. (2026). A self-complementary recombinant adeno-associated virus vector coding for an anchorless prion protein carrying the G127V mutation extends survival in a rodent prion disease model. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1014124

Vancouver

Zerbes T, Verkuyl C, Zhang C, Grunnesjoe S, Eid S, Arshad H, et al. A self-complementary recombinant adeno-associated virus vector coding for an anchorless prion protein carrying the G127V mutation extends survival in a rodent prion disease model. PLOS Pathogens. 2026. doi:10.1371/journal.ppat.1014124

BibTeX
@article{Zerbes2026,
  author = {Zerbes, Thomas and Verkuyl, Claire and Zhang, Cunjie and Grunnesjoe, Sophie and Eid, Shehab and Arshad, Hamza and Zhao, Wenda and Nasser, Zahra and O'Shea, Teaghan and Bel, Ari and Lamoureux, Lise and Frost, Kathy L and Myskiw, Jennifer and Li, Le Yao and Stuart, Erica and Wille, Holger and Booth, Stephanie and Watts, Joel C and Schmitt-Ulms, Gerold},
  title = {A self-complementary recombinant adeno-associated virus vector coding for an anchorless prion protein carrying the G127V mutation extends survival in a rodent prion disease model},
  journal = {PLOS Pathogens},
  year = {2026},
  doi = {10.1371/journal.ppat.1014124}
}
Kostenlos starten →